HeartSciences

Q4 FY2026 EarningsHSCS FY2026 results missed consensus estimates significantly, reporting no meaningful revenue against an expectation of $50,000 for the period. The company ended the fiscal year with a fragile liquidity position of $1.7M in cash and just $0.2M in shareholders' equity. Management is pivoting via a proposed transformational merger with Fortitude Mining Holdings to enter the Zcash ecosystem, essentially shifting from MedTech R&D to digital asset mining to address Nasdaq listing deficiencies and funding shortfalls.